For patient referrals: call 602-521-3090What if one of the most overlooked heart valve conditions finally had a minimally invasive solution? In this episode of Beyond the Rounds, we explore tricuspid valve disease — often underdiagnosed and undertreated — and the emerging transcatheter therapies that are transforming care. Dr. Nolan Fisher sits down with interventional cardiologist Dr. Paul Sorajja to discuss how innovations like the TriClip procedure are improving quality of life for patients who previously had limited or high-risk treatment options.Often referred to as the “forgotten valve,” the tricuspid valve can quietly lead to significant symptoms, including fatigue, edema and organ dysfunction. With advances in catheter-based repair techniques, clinicians now have new tools to treat tricuspid regurgitation without open-heart surgery — offering meaningful symptom relief with low procedural risk.This episode explores how these therapies work, which patients may benefit, and how evolving data is shaping the future of valvular heart disease treatment.This episode is designed for physicians, advanced practice providers and clinicians seeking a practical understanding of transcatheter valve therapies and the management of tricuspid disease.What We Cover• Why tricuspid valve disease is frequently missed or undertreated• The difference between valve repair vs. replacement• How transcatheter therapies (like TriClip) work• Patient selection and when intervention is appropriate• The role of imaging and echocardiography in diagnosis• Understanding symptoms of tricuspid regurgitation• Cardiorenal syndrome and systemic effects of valve disease• Clinical trial insights, including the TRILUMINATE study• Why quality-of-life improvements matter — even without mortality benefit• The importance of a multidisciplinary “heart team” approachKey Topics for CliniciansTricuspid regurgitation (TR)Valvular heart diseaseStructural heart interventionsTranscatheter valve repairTriClip procedureCardiorenal syndromeRight-sided heart failureEchocardiography in valve diseaseInterventional cardiology innovationMultidisciplinary heart team careAbout Our GuestDr. Paul Sorajja is an interventional cardiologist and Director of Interventional Cardiology at Banner - University Medicine Heart Institute. He is a nationally recognized leader in structural heart disease and has been at the forefront of developing transcatheter valve therapies, including early work in tricuspid valve repair. Dr. Sorajja trained at Mayo Clinic, where he spent two decades advancing minimally invasive cardiovascular treatments and leading clinical research.He sees patients at:Banner - University Medicine Heart Institute755 East McDowell Road, Floor 4Phoenix, AZ 85006Banner Health Center plus at Arcadia4200 East Camelback Road, Suite 202Phoenix, AZ 85018Phone: 602-521-3090Fax: 602-521-3661How to Refer a PatientBanner Health providers: Use Cerner’s Ambulatory Referral Management (ARM) tool.Community providers:Fax referrals to 602-521-3661 or call 602-521-3090 to schedule a patient for evaluation.DisclaimerThis podcast is intended for educational purposes only and is designed for a clinical audience. Any patient scenarios discussed are modified and de-identified to protect privacy. No protected health information (PHI) is disclosed. The information presented should not replace independent medical judgment or individualized patient care decisions.Subscribe to Beyond the Rounds for physician-focused conversations on clinical innovation, specialty collaboration and evolving standards of care.